UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder

European urology, 2013-02, Vol.63 (2), p.296-305

2013

Volltextzugriff (PDF)

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

European urology, 2020-01, Vol.77 (1), p.119-128

2020

Volltextzugriff (PDF)

Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review

European urology, 2019-03, Vol.75 (3), p.464-476

2019

Volltextzugriff (PDF)

Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair

European urology focus, 2019-03, Vol.5 (2), p.280-289

2019

Volltextzugriff (PDF)

A phase II dose-ranging study of mirabegron in patients with overactive bladder

International Urogynecology Journal, 2013-09, Vol.24 (9), p.1447-1458

2013

Volltextzugriff (PDF)

Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

World journal of urology, 2014-12, Vol.32 (6), p.1565-1572

2014

Volltextzugriff (PDF)

The placebo effect in overactive bladder syndrome

Nature reviews. Urology, 2011-09, Vol.8 (9), p.495

2011

Volltextzugriff (PDF)

Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH

World journal of urology, 2015-05, Vol.33 (5), p.697-706

2015

Volltextzugriff (PDF)

Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder

Expert opinion on pharmacotherapy, 2006-12, Vol.7 (17), p.2421-2434

Chapple, Christopher R

2006

Volltextzugriff (PDF)

Effect of an ATP-Sensitive Potassium Channel Opener in Subjects with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Study (ZD0947IL/0004)

European urology, 2006-05, Vol.49 (5), p.879-886

2006

Volltextzugriff (PDF)

An Open, Multicentre Study of NASHA/Dx Gel (Zuidex™) for the Treatment of Stress Urinary Incontinence

European urology, 2005-09, Vol.48 (3), p.488-494

2005

Volltextzugriff (PDF)

Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial

European urology, 2013-02, Vol.63 (2), p.283-295

2013

Volltextzugriff (PDF)

Lower urinary tract symptoms in men

BMJ (British Medical Journal), 2007-01, Vol.334 (7583), p.2-2

2007

Volltextzugriff (PDF)

Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy

International Urogynecology Journal, 2007-02, Vol.18 (2), p.199-205

2007

Volltextzugriff (PDF)

Efficacy and Safety of Combination Pharmacotherapy for Patients with Overactive Bladder: A Rapid Evidence Assessment

European urology, 2019-12, Vol.76 (6), p.767-779

2019

Volltextzugriff (PDF)

The use of laser as a therapeutic modality as compared to TURP for the small prostate ≤40 mL: a collaborative review

Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2019-12, Vol.71 (6), p.569

2019

Volltextzugriff (PDF)

Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study

European urology focus, 2024-01, Vol.10 (1), p.90-97

2024

Volltextzugriff (PDF)

Assessment of Electrospun and Ultra-lightweight Polypropylene Meshes in the Sheep Model for Vaginal Surgery

European urology focus, 2020-01, Vol.6 (1), p.190-198

2020

Volltextzugriff (PDF)

Tamsulosin: an overview

World journal of urology, 2002-04, Vol.19 (6), p.397-404

2002

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionWiley Journals

SpracheJapanisch

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Urology & Nephrology
(16)
Male
(12)
Female
(11)
Aged
(8)
Middle Aged
(8)
Quality Of Life
(8)
Double-Blind Method
(7)
Urinary Bladder, Overactive - Drug Therapy
(7)
Adrenergic Beta-3 Receptor Agonists - Therapeutic Use
(6)
Urology
(6)
Acetanilides - Therapeutic Use
(5)
Muscarinic Antagonists - Therapeutic Use
(5)
Overactive Bladder
(5)
Thiazoles - Therapeutic Use
(5)
Adult
(4)
Dose-Response Relationship, Drug
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review

Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair

A phase II dose-ranging study of mirabegron in patients with overactive bladder

Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

The placebo effect in overactive bladder syndrome

Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH

Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder

Effect of an ATP-Sensitive Potassium Channel Opener in Subjects with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Study (ZD0947IL/0004)

An Open, Multicentre Study of NASHA/Dx Gel (Zuidex™) for the Treatment of Stress Urinary Incontinence

Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial

Lower urinary tract symptoms in men

Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy

Efficacy and Safety of Combination Pharmacotherapy for Patients with Overactive Bladder: A Rapid Evidence Assessment

The use of laser as a therapeutic modality as compared to TURP for the small prostate ≤40 mL: a collaborative review

Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study

Assessment of Electrospun and Ultra-lightweight Polypropylene Meshes in the Sheep Model for Vaginal Surgery

Tamsulosin: an overview

Aktive Filter

Suchergebnisse filtern